Cramer's Mad Money - Thank Heaven For Alcoa (1/9/13)

by: Miriam Metzinger

Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday January 9.

Alcoa (NYSE:AA)

"Thank heavens earnings started with Alcoa," said Cramer, "and I haven't said that for a long time." Alcoa has the tendency to disappoint on earnings, but this time, the company's aluminum forecasts were higher than The Street expected, 7-8% compared to 6% last year. China's forecasted double digit GDP of 11% will be good for Alcoa, and the economic expansion in Russia, Brazil and India will benefit Alcoa as well. The auto buildout in the U.S. is another plus, and Alcoa is seeing improvement in cash flow and productivity. For the first time in a while, Alcoa gave a strong start to earnings season.

Stryker (NYSE:SYK), Seagate (NASDAQ:STX), Boeing (NYSE:BA), United Technologies (NYSE:UTX), Honeywell (NYSE:HON), Joy Global (NYSE:JOY), iShares FTSE China 25 Index (NYSEARCA:FXI), Broadcom (BRCM), Facebook (NASDAQ:FB), Goodrich (NYSE:GR)

The Dow gained 62 points on Wednesday with good news from companies like Stryker (SYK) and Seagate (STX) which gave numbers exceeding The Street's expectations, in spite of a generally declining PC market. Alcoa transcended worries about an aluminum glut and gave strong indication that the building boom in China will trump commodity concerns.

Cramer discussed two bull markets for 2013: aerospace and China. Boeing (BA) is surpassing Airbus as the world's leading producer of planes. There are some worries about possible defects in the Dreamliner, but Boeing management said there is no slowdown in orders. United Technologies (UTX) might be a better aerospace stock to buy, especially with its acquisition of Goodrich (GR). Honeywell (HON), which makes parts for planes, is a solid stock, but since it has run up, Cramer would wait for a pullback. With China on the rebound, Cramer would consider buying Joy Global (JOY), given the strength of demand for coal in the region. The stock is up 10% in only two weeks, so Cramer would buy it on a decline. The best way to invest in China, according to Cramer, is the iShares FTSE China 25 Index (FXI).

Cramer took some calls:

Broadcom (BRCM) is a stock to buy for investors who want exposure to chips.

Facebook (FB) should see some upside, but Cramer would wait for a pullback.

CEO Interview: Dr. Ron Cohen, Acorda Therapeutics (NASDAQ:ACOR)

Acorda (ACOR) gave a presentation at the JPMorgan Healthcare conference on its drug for multiple sclerosis. The drug is being tested for possible further indications, including the treatment of cerebral palsy and chronic strokes. While physical therapy is helpful, CEO Dr. Ron Cohen emphasized the importance of the right drug to treat nervous system disorders. The stock has risen on the positive data from ACOR, and may be a buy on a dip.

CEO Interview: James Foster, Charles River Laboratories (NYSE:CRL)

For investors who want exposure to biotech, but do not want to play the FDA approval Russian roulette, Cramer recommended Charles River Laboratories (CRL) the "arms dealer" for biotech. The company makes equipment used in testing treatments and should benefit from the increased outsourcing of lab work by large pharmaceutical companies. The outsourcing allows CRL to grab more market share, and CEO James Foster explained that CRL expects to have most of the major pharmas as clients. Cramer thinks CRL will see a significant upside by the latter part of 2013.


Jim Cramer was up 31% in 2009. Click here now to trade alongside him.

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.